Central Amygdala Neuroplasticity in Alcohol Dependence

Neurobiology of Alcohol Dependence

Volumn , Issue , 2014, Pages 207-226

  Roberto, Marisa ^a   Gilpin, Nicholas W ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Alcohol dependence; Cannabinoids; Central amygdala; CRF; Ethanol; GABA; Ghrelin; N OFQ; NPY

Indexed keywords

EID: 84902405922     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405941-2.00011-0     Document Type: Chapter

References (222)

1. Addolorato G., Capristo E., Leggio L., Ferrulli A., Abenavoli L., Malandrino N., et al. Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. Alcoholism, Clinical and Experimental Research 2006, 30(11):1933-1937.
2. Addolorato G., Leggio L., Hillemacher T., Kraus T., Jerlhag E., Bleich S. Hormones and drinking behaviour: New findings on ghrelin, insulin, leptin and volume-regulating hormones. An ESBRA Symposium report. Drug and Alcohol Review 2009, 28(2):160-165.
3. Alheid G.F., Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 1988, 27(1):1-39.
4. Allen Y.S., Roberts G.W., Bloom S.R., Crow T.J., Polak J.M. Neuropeptide Y in the stria terminalis: Evidence for an amygdalofugal projection. Brain Research 1984, 321(2):357-362.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, DC. 4th ed.
6. Andreasen M., Hablitz J.J. Paired-pulse facilitation in the dentate gyrus: A patch-clamp study in rat hippocampus in vitro. Journal of Neurophysiology 1994, 72(1):326-336.
7. Antoni F.A. Molecular diversity of cyclic AMP signalling. Frontiers in Neuroendocrinology 2000, 21(2):103-132.
8. Antoni F.A., Sosunov A.A., Haunso A., Paterson J.M., Simpson J. Short-term plasticity of cyclic adenosine 3',5'-monophosphate signaling in anterior pituitary corticotrope cells: The role of adenylyl cyclase isotypes. Molecular Endocrinology 2003, 17(4):692-703.
9. Arborelius L., Skelton K.H., Thrivikraman K.V., Plotsky P.M., Schulz D.W., Owens M.J. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: Behavioral, endocrine and neurochemical effects in the rat. Journal of Pharmacology and Experimental Therapeutics 2000, 294(2):588-597.
10. Ariwodola O.J., Weiner J.L. Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: Role of presynaptic GABAB receptors. Journal of Neuroscience 2004, 24(47):10679-10686.
11. Badaoui A., De Saeger C., Duchemin J., Gihousse D., de Timary P., Starkel P. Alcohol dependence is associated with reduced plasma and fundic ghrelin levels. European Journal of Clinical Investigation 2008, 38(6):397-403.
12. Bajo M., Cruz M.T., Siggins G.R., Messing R., Roberto M. Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(24):8410-8415.
13. Beadles-Bohling A.S., Crabbe J.C., Wiren K.M. Elevated prodynorphin expression associated with ethanol withdrawal convulsions. Neurochemistry International 2000, 37(5-6):463-472.
14. Bonci A., Williams J.T. Increased probability of GABA release during withdrawal from morphine. Journal of Neuroscience 1997, 17(2):796-803.
15. Boyle A.E., Segal R., Smith B.R., Amit Z. Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats. Pharmacology, Biochemistry and Behavior 1993, 46(1):179-182.
16. Britton K.T., Southerland S., Van Uden E., Kirby D., Rivier J., Koob G. Anxiolytic activity of NPY receptor agonists in the conflict test. Psychopharmacology (Berl) 1997, 132(1):6-13.
17. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., Junien J.L. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behavioural Pharmacology 1995, 6(3):215-222.
18. Carta M., Mameli M., Valenzuela C.F. Alcohol enhances GABAergic transmission to cerebellar granule cells via an increase in Golgi cell excitability. Journal of Neuroscience 2004, 24(15):3746-3751.
19. Cassell M.D., Freedman L.J., Shi C. The intrinsic organization of the central extended amygdala. Annals of the New York Academy of Sciences 1999, 877:217-241.
20. Cassell M.D., Gray T.S., Kiss J.Z. Neuronal architecture in the rat central nucleus of the amygdala: A cytological, hodological, and immunocytochemical study. Journal of Comparative Neurology 1986, 246(4):478-499.
21. Chen X., DiMaggio D.A., Han S.P., Westfall T.C. Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors. American Journal of Physiology 1997, 273(4 Pt 2):H1737-H1744.
22. Chen G., van den Pol A.N. Multiple NPY receptors coexist in pre- and postsynaptic sites: Inhibition of GABA release in isolated self-innervating SCN neurons. Journal of Neuroscience 1996, 16(23):7711-7724.
23. Chheda M.G., Ashery U., Thakur P., Rettig J., Sheng Z.H. Phosphorylation of Snapin by PKA modulates its interaction with the SNARE complex. Nature Cell Biology 2001, 3(4):331-338.
24. Choi D.S., Wang D., Dadgar J., Chang W.S., Messing R.O. Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice. Journal of Neuroscience 2002, 22(22):9905-9911.
25. Chu K., Koob G.F., Cole M., Zorrilla E.P., Roberts A.J. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacology, Biochemistry and Behavior 2007, 86(4):813-821.
26. Ciccocioppo R., Cippitelli A., Economidou D., Fedeli A., Massi M. Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect. Physiology & Behavior 2004, 82(1):63-68.
27. Ciccocioppo R., Economidou D., Cippitelli A., Cucculelli M., Ubaldi M., Soverchia L., et al. Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: An animal model to study the neurobiology of alcoholism. Addiction Biology 2006, 11(3-4):339-355.
28. Ciccocioppo R., Economidou D., Fedeli A., Angeletti S., Weiss F., Heilig M., et al. Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology (Berl) 2004, 172(2):170-178.
29. Ciccocioppo R., Economidou D., Rimondini R., Sommer W., Massi M., Heilig M. Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system. Biological Psychiatry 2007, 61(1):4-12.
30. Ciccocioppo R., Panocka I., Polidori C., Regoli D., Massi M. Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology (Berl) 1999, 141(2):220-224.
31. Cippitelli A., Damadzic R., Singley E., Thorsell A., Ciccocioppo R., Eskay R.L., et al. Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats. Pharmacology, Biochemistry and Behavior 2012, 100(3):522-529.
32. Colombo G., Serra S., Brunetti G., Gomez R., Melis S., Vacca G., et al. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (Berl) 2002, 159(2):181-187. 10.1007/s002130100887.
33. Colombo G., Serra S., Vacca G., Carai M.A., Gessa G.L. Endocannabinoid system and alcohol addiction: Pharmacological studies. Pharmacology, Biochemistry and Behavior 2005, 81(2):369-380.
34. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37(4):649-661.
35. Criado J.R., Morales M. Acute ethanol induction of c-Fos immunoreactivity in pre-pro-enkephalin expressing neurons of the central nucleus of the amygdala. Brain Research 2000, 861(1):173-177.
36. Cruz M.T., Bajo M., Magnoli E.M., Tabakoff B., Siggins G.R., Roberto M. Type 7 Adenylyl Cyclase is Involved in the Ethanol and CRF sensitivity of GABAergic synapses in mouse central amygdala. Frontiers in Neuroscience 2011, 4:207.
37. Cruz M.T., Herman M.A., Cote D.M., Ryabinin A.E., Roberto M. Ghrelin increases GABAergic transmission and interacts with ethanol actions in the rat central nucleus of the amygdala. Neuropsychopharmacology 2013, 38(2):364-375.
38. Cruz M.T., Herman M.A., Kallupi M., Roberto M. Nociceptin/orphanin FQ blockade of corticotropin-releasing factor-induced gamma-aminobutyric acid release in central amygdala is enhanced after chronic ethanol exposure. Biological Psychiatry 2012, 71(8):666-676.
39. Davis M., Walker D.L., Miles L., Grillon C. Phasic vs sustained fear in rats and humans: Role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010, 35(1):105-135.
40. De Koninck Y., Mody I. Noise analysis of miniature IPSCs in adult rat brain slices: Properties and modulation of synaptic GABAA receptor channels. Journal of Neurophysiology 1994, 71(4):1318-1335.
41. De Olmos J., Alheid G.F., Beltamino C.A. Amygdala. The rat nervous system 1985, 223-335. Academic Press. G. Paxinos (Ed.).
42. de Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-II. Immunohistochemical analysis. Neuroscience 1986, 18(3):545-618.
43. De Souza E.B., Perrin M.H., Insel T.R., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors in rat forebrain: Autoradiographic identification. Science 1984, 224(4656):1449-1451.
44. Debanne D., Guerineau N.C., Gahwiler B.H., Thompson S.M. Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: Quantal fluctuation affects subsequent release. Journal of Physiology 1996, 491(Pt 1):163-176.
45. Dumont Y., Fournier A., St-Pierre S., Quirion R. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. Journal of Neuroscience 1993, 13(1):73-86.
46. Economidou D., Cippitelli A., Stopponi S., Braconi S., Clementi S., Ubaldi M., et al. Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat. Alcoholism, Clinical and Experimental Research 2011, 35(4):747-755.
47. Economidou D., Hansson A.C., Weiss F., Terasmaa A., Sommer W.H., Cippitelli A., et al. Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biological Psychiatry 2008, 64(3):211-218.
48. Edenberg H.J., Wang J., Tian H., Pochareddy S., Xuei X., Wetherill L., et al. A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence. Human Molecular Genetics 2008, 17(12):1783-1789.
49. Edwards S., Kenna G.A., Swift R.M., Leggio L. Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: A review. Current Pharmaceutical Design 2011, 17(14):1323-1332.
50. Filliol D., Ghozland S., Chluba J., Martin M., Matthes H.W., Simonin F., et al. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nature Genetics 2000, 25(2):195-200.
51. Finnegan T.F., Chen S.R., Pan H.L. Effect of the μ opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala. Journal of Pharmacology and Experimental Therapeutics 2005, 312(2):441-448.
52. Foster K.L., McKay P.F., Seyoum R., Milbourne D., Yin W., Sarma P.V., et al. GABA(A) and opioid receptors of the central nucleus of the amygdala selectively regulate ethanol-maintained behaviors. Neuropsychopharmacology 2004, 29(2):269-284.
53. Funk C.K., O'Dell L.E., Crawford E.F., Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. Journal of Neuroscience 2006, 26(44):11324-11332.
54. Funk C.K., Zorrilla E.P., Lee M.J., Rice K.C., Koob G.F. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biological Psychiatry 2007, 61(1):78-86.
55. Furness J.B., Hunne B., Matsuda N., Yin L., Russo D., Kato I., et al. Investigation of the presence of ghrelin in the central nervous system of the rat and mouse. Neuroscience 2011, 193:1-9.
56. Gehlert D.R., Cippitelli A., Thorsell A., Le A.D., Hipskind P.A., Hamdouchi C., et al. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo [1,2-b]pyridazine: A novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. Journal of Neuroscience 2007, 27(10):2718-2726.
57. Gessa G.L., Serra S., Vacca G., Carai M.A., Colombo G. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats. Alcohol Alcohol 2005, 40(1):46-53.
58. Gilpin N.W., Roberto M., Koob G.F., Schweitzer P. Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala. Neuropharmacol 2014, 77:294-302.
59. Gilpin N.W., Misra K., Herman M.A., Cruz M.T., Koob G.F., Roberto M. Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence. Biological Psychiatry 2011, 69(11):1091-1099.
60. Gilpin N.W., Misra K., Koob G.F. Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking. Pharmacology, Biochemistry and Behavior 2008, 90(3):475-480.
61. Gilpin N.W., Richardson H.N., Cole M., Koob G.F. Vapor inhalation of alcohol in rats. Current Protocols in Neuroscience 2008, Unit 9.29.
62. Gilpin N.W., Richardson H.N., Koob G.F. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcoholism, Clinical and Experimental Research 2008, 32(9):1535-1542.
63. Gilpin N.W., Stewart R.B., Badia-Elder N.E. Neuropeptide Y administration into the amygdala suppresses ethanol drinking in alcohol-preferring (P) rats following multiple deprivations. Pharmacology, Biochemistry and Behavior 2008, 90(3):470-474.
64. Gilpin N.W., Stewart R.B., Badia-Elder N.E. Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non-ethanol-abstinent, Wistar rats. Alcohol 2008, 42(7):541-551.
65. Glykys J., Mody I. Activation of GABAA receptors: Views from outside the synaptic cleft. Neuron 2007, 56(5):763-770.
66. Glykys J., Peng Z., Chandra D., Homanics G.E., Houser C.R., Mody I. A new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanol. Nature Neuroscience 2007, 10(1):40-48.
67. Greber S., Schwarzer C., Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. British Journal of Pharmacology 1994, 113(3):737-740.
68. Gustafson E.L., Smith K.E., Durkin M.M., Walker M.W., Gerald C., Weinshank R., et al. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Brain Research. Molecular Brain Research 1997, 46(1-2):223-235.
69. Hanoune J., Defer N. Regulation and role of adenylyl cyclase isoforms. Annual Review of Pharmacology and Toxicology 2001, 41:145-174.
70. Hansson A.C., Cippitelli A., Sommer W.H., Fedeli A., Bjork K., Soverchia L., et al. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(41):15236-15241.
71. Haubensak W., Kunwar P.S., Cai H., Ciocchi S., Wall N.R., Ponnusamy R., et al. Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 2010, 468(7321):270-276.
72. Heilig M., McLeod S., Brot M., Heinrichs S.C., Menzaghi F., Koob G.F., et al. Anxiolytic-like action of neuropeptide Y: Mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 1993, 8(4):357-363.
73. Heilig M., Soderpalm B., Engel J.A., Widerlov E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl) 1989, 98(4):524-529.
74. Herman M.A., Contet C., Justice N.J., Vale W., Roberto M. Novel subunit-specific tonic GABA currents and differential effects of ethanol in the central amygdala of CRF receptor-1 reporter mice. Journal of Neuroscience 2013, 33(8):3284-3298.
75. Heyser C.J., Roberts A.J., Schulteis G., Koob G.F. Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. Alcoholism, Clinical and Experimental Research 1999, 23(9):1468-1476.
76. Hodge C.W., Mehmert K.K., Kelley S.P., McMahon T., Haywood A., Olive M.F., et al. Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nature Neuroscience 1999, 2(11):997-1002.
77. Hodge C.W., Raber J., McMahon T., Walter H., Sanchez-Perez A.M., Olive M.F., et al. Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. Journal of Clinical Investigation 2002, 110(7):1003-1010.
78. Hopkins D.A., Holstege G. Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat. Experimental Brain Research 1978, 32(4):529-547.
79. Huang M.M., Overstreet D.H., Knapp D.J., Angel R., Wills T.A., Navarro M., et al. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: Relation to stress-induced sensitization. Journal of Pharmacology and Experimental Therapeutics 2010, 332(1):298-307.
80. Hungund B.L., Basavarajappa B.S., Vadasz C., Kunos G., Rodriguez de Fonseca F., Colombo G., et al. Ethanol, endocannabinoids, and the cannabinoidergic signaling system. Alcoholism, Clinical and Experimental Research 2002, 26(4):565-574.
81. Hungund B.L., Szakall I., Adam A., Basavarajappa B.S., Vadasz C. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. Journal of Neurochemistry 2003, 84(4):698-704.
82. Hyytia P., Koob G.F. GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. European Journal of Pharmacology 1995, 283(1-3):151-159.
83. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma F.J., et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(26):14854-14858.
84. Jenck F., Ouagazzal A.M., Pauly-Evers M., Moreau J.L. OrphaninFQ: Role in behavioral fear responses and vulnerability to stress?. Molecular Psychiatry 2000, 5(6):572-574.
85. Jerlhag E., Egecioglu E., Landgren S., Salome N., Heilig M., Moechars D., et al. Requirement of central ghrelin signaling for alcohol reward. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(27):11318-11323.
86. Jia F., Chandra D., Homanics G.E., Harrison N.L. Ethanol modulates synaptic and extrasynaptic GABAA receptors in the thalamus. Journal of Pharmacology and Experimental Therapeutics 2008, 326(2):475-482.
87. Jolkkonen E., Pitkanen A. Intrinsic connections of the rat amygdaloid complex: Projections originating in the central nucleus. Journal of Comparative Neurology 1998, 395(1):53-72.
88. Justice N.J., Yuan Z.F., Sawchenko P.E., Vale W. Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: Implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system. Journal of Comparative Neurology 2008, 511(4):479-496.
89. Kallupi M., Vendruscolo L.F., Carmichael C.Y., George O., Koob G.F., Gilpin N.W. Neuropeptide Y Y R blockade in the central amygdala reduces anxiety-like behavior but not alcohol drinking in alcohol-dependent rats. Addiction Biology 2013, 10.1111/adb.12059.
90. Kang-Park M.H., Kieffer B.L., Roberts A.J., Roberto M., Madamba S.G., Siggins G.R., et al. Mu-opioid receptors selectively regulate basal inhibitory transmission in the central amygdala: Lack of ethanol interactions. Journal of Pharmacology and Experimental Therapeutics 2009, 328(1):284-293.
91. Kang-Park M.H., Kieffer B.L., Roberts A.J., Siggins G.R., Moore S.D. Presynaptic delta opioid receptors regulate ethanol actions in central amygdala. Journal of Pharmacology and Experimental Therapeutics 2007, 320(2):917-925.
92. Kang-Park M., Kieffer B.L., Roberts A.J., Siggins G.R., Moore S.D. Kappa-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic Sites. Journal of Pharmacology and Experimental Therapeutics 2013, 346(1):130-137.
93. Kash T.L., Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 2006, 51(5):1013-1022.
94. Kelm M.K., Criswell H.E., Breese G.R. The role of protein kinase A in the ethanol-induced increase in spontaneous GABA release onto cerebellar Purkinje neurons. Journal of Neurophysiology 2008, 100(6):3417-3428.
95. Kelm M.K., Weinberg R.J., Criswell H.E., Breese G.R. The PLC/IP 3 R/PKC pathway is required for ethanol-enhanced GABA release. Neuropharmacology 2010, 58(7):1179-1186.
96. Kim D.J., Yoon S.J., Choi B., Kim T.S., Woo Y.S., Kim W., et al. Increased fasting plasma ghrelin levels during alcohol abstinence. Alcohol and Alcoholism 2005, 40(1):76-79.
97. Koob G.F. Alcoholism: Allostasis and beyond. Alcoholism, Clinical and Experimental Research 2003, 27(2):232-243.
98. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59(1):11-34.
99. Koster A., Montkowski A., Schulz S., Stube E.M., Knaudt K., Jenck F., et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(18):10444-10449.
100. Kovacs K.M., Szakall I., O'Brien D., Wang R., Vinod K.Y., Saito M., et al. Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcoholism, Clinical and Experimental Research 2005, 29(5):730-738.
101. Kraus T., Schanze A., Groschl M., Bayerlein K., Hillemacher T., Reulbach U., Bleich S. Ghrelin levels are increased in alcoholism. Alcoholism, Clinical and Experimental Research 2005, 29(12):2154-2157.
102. Krettek J.E., Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. Journal of Comparative Neurology 1978, 178(2):225-254.
103. Kuzmin A., Kreek M.J., Bakalkin G., Liljequist S. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking. Neuropsychopharmacology 2007, 32(4):902-910.
104. Kuzmin A., Madjid N., Johansson B., Terenius L., Ogren S.O. The nociceptin system and hippocampal cognition in mice: A pharmacological and genetic analysis. Brain Research 2009, 1305(Suppl: S7-19).
105. Kuzmin A., Sandin J., Terenius L., Ogren S.O. Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: Effects of opioid receptor-like 1 receptor agonists and naloxone. Journal of Pharmacology and Experimental Therapeutics 2003, 304(1):310-318.
106. Lam M.P., Marinelli P.W., Bai L., Gianoulakis C. Effects of acute ethanol on opioid peptide release in the central amygdala: An in vivo microdialysis study. Psychopharmacology (Berl) 2008, 201(2):261-271.
107. Land B.B., Bruchas M.R., Lemos J.C., Xu M., Melief E.J., Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. Journal of Neuroscience 2008, 28(2):407-414.
108. Landgren S., Berglund K., Jerlhag E., Fahlke C., Balldin J., Berggren U., et al. Reward-related genes and personality traits in alcohol-dependent individuals: A pilot case control study. Neuropsychobiology 2011, 64(1):38-46.
109. Landgren S., Engel J.A., Hyytia P., Zetterberg H., Blennow K., Jerlhag E. Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference. Behavioural Brain Research 2011, 221(1):182-188.
110. Landgren S., Jerlhag E., Zetterberg H., Gonzalez-Quintela A., Campos J., Olofsson U., et al. Association of pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes with heavy alcohol use and body mass. Alcoholism, Clinical and Experimental Research 2008, 32(12):2054-2061.
111. Landgren S., Simms J.A., Thelle D.S., Strandhagen E., Bartlett S.E., Engel J.A., et al. The ghrelin signalling system is involved in the consumption of sweets. PLoS One 2011, 6(3):e18170.
112. Le Gal LaSalle G., Paxinos G., Ben-Ari Y. Neurochemical mapping of GABAergic systems in the amygdaloid complex and bed nucleus of the stria terminalis. Brain Research 1978, 155(2):397-403.
113. Lee Y., Fitz S., Johnson P.L., Shekhar A. Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology 2008, 33(11):2586-2594.
114. Leenders A.G., Sheng Z.H. Modulation of neurotransmitter release by the second messenger-activated protein kinases: Implications for presynaptic plasticity. Pharmacology and Therapeutics 2005, 105(1):69-84.
115. Leggio L., Addolorato G., Cippitelli A., Jerlhag E., Kampov-Polevoy A.B., Swift R.M. Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelin. Alcoholism, Clinical and Experimental Research 2011, 35(2):194-202.
116. Li H., Penzo M.A., Taniguchi H., Kopec C.D., Huang Z.J., Li B. Experience-dependent modification of a central amygdala fear circuit. Nature Neuroscience 2013, 16(3):332-339.
117. Li C., Pleil K.E., Stamatakis A.M., Busan S., Vong L., Lowell B.B., et al. Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling. Biological Psychiatry 2012, 71(8):725-732.
118. Liang J., Spigelman I., Olsen R.W. Tolerance to sedative/hypnotic actions of GABAergic drugs correlates with tolerance to potentiation of extrasynaptic tonic currents of alcohol-dependent rats. Journal of Neurophysiology 2009, 102(1):224-233.
119. Liang J., Suryanarayanan A., Abriam A., Snyder B., Olsen R.W., Spigelman I. Mechanisms of reversible GABAA receptor plasticity after ethanol intoxication. Journal of Neuroscience 2007, 27(45):12367-12377.
120. Lochner A., Moolman J.A. The many faces of H89: A review. Cardiovascular Drug Reviews 2006, 24(3-4):261-274.
121. Lovinger D.M., Roberto M. Synaptic effects induced by alcohol. Current Topics in Behavioral Neurosciences 2011, 13:31-86. 10.1007/7854_2011_143.
122. Lowery E.G., Spanos M., Navarro M., Lyons A.M., Hodge C.W., Thiele T.E. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology 2010, 35(6):1241-1252.
123. Lowery E.G., Sparrow A.M., Breese G.R., Knapp D.J., Thiele T.E. The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcoholism, Clinical and Experimental Research 2008, 32(2):240-248.
124. Lowery-Gionta E.G., Navarro M., Li C., Pleil K.E., Rinker J.A., Cox B.R., et al. Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. Journal of Neuroscience 2012, 32(10):3405-3413.
125. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 1998, 394(6693):577-581.
126. Manabe T., Renner P., Nicoll R.A. Postsynaptic contribution to long-term potentiation revealed by the analysis of miniature synaptic currents. Nature 1992, 355(6355):50-55.
127. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. Journal of Neuroscience 1987, 7(8):2445-2464.
128. Marchant N.J., Densmore V.S., Osborne P.B. Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: Evidence of two distinct endogenous opioid systems in the lateral division. Journal of Comparative Neurology 2007, 504(6):702-715.
129. Marinelli P.W., Funk D., Juzytsch W., Harding S., Rice K.C., Shaham Y., et al. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl) 2007, 195(3):345-355.
130. Martin-Fardon R., Ciccocioppo R., Massi M., Weiss F. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. NeuroReport 2000, 11(9):1939-1943.
131. Martin-Fardon R., Zorrilla E.P., Ciccocioppo R., Weiss F. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Research 2010, 1314:145-161.
132. Matsuzawa S., Suzuki T., Misawa M., Nagase H. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress. European Journal of Pharmacology 1999, 368(1):9-16.
133. McDonald A.J., Augustine J.R. Localization of GABA-like immunoreactivity in the monkey amygdala. Neuroscience 1993, 52(2):281-294.
134. Mennerick S., Zorumski C.F. Paired-pulse modulation of fast excitatory synaptic currents in microcultures of rat hippocampal neurons. Journal of Physiology 1995, 488(Pt 1):85-101.
135. Merlo Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. Journal of Neuroscience 1995, 15(8):5439-5447.
136. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. European Journal of Pharmacology 1997, 340(1):1-15.
137. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor- like ORL1 receptor. Nature 1995, 377(6549):532-535.
138. Migita K., Loewy A.D., Ramabhadran T.V., Krause J.E., Waters S.M. Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system. Brain Research 2001, 889(1-2):23-37.
139. Mody I., Glykys J., Wei W. A new meaning for "Gin & Tonic": Tonic inhibition as the target for ethanol action in the brain. Alcohol 2007, 41(3):145-153.
140. 2+-sensitive adenylyl cyclases, key integrators of cellular signalling. Life Sciences 1998, 62(17-18):1647-1652.
141. Mons N., Yoshimura M., Ikeda H., Hoffman P.L., Tabakoff B. Immunological assessment of the distribution of type VII adenylyl cyclase in brain. Brain Research 1998, 788(1-2):251-261.
142. Muller M.B., Zimmermann S., Sillaber I., Hagemeyer T.P., Deussing J.M., Timpl P., et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nature Neuroscience 2003, 6(10):1100-1107.
143. Nguyen P.V., Woo N.H. Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Progress in Neurobiology 2003, 71(6):401-437.
144. Nie Z., Madamba S.G., Siggins G.R. Ethanol enhances gamma-aminobutyric acid responses in a subpopulation of nucleus accumbens neurons: Role of metabotropic glutamate receptors. Journal of Pharmacology and Experimental Therapeutics 2000, 293(2):654-661.
145. Nie H., Rewal M., Gill T.M., Ron D., Janak P.H. Extrasynaptic delta-containing GABAA receptors in the nucleus accumbens dorsomedial shell contribute to alcohol intake. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(11):4459-4464.
146. Nie Z., Schweitzer P., Roberts A.J., Madamba S.G., Moore S.D., Siggins G.R. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 2004, 303(5663):1512-1514.
147. Nie Z., Yuan X., Madamba S.G., Siggins G.R. Ethanol decreases glutamatergic synaptic transmission in rat nucleus accumbens in vitro: Naloxone reversal. Journal of Pharmacology and Experimental Therapeutics 1993, 266(3):1705-1712.
148. Nie Z., Zorrilla E.P., Madamba S.G., Rice K.C., Roberto M., Siggins G.R. Presynaptic CRF1 receptors mediate the ethanol enhancement of GABAergic transmission in the mouse central amygdala. Scientific World Journal 2009, 9:68-85.
149. Olive M.F., Mehmert K.K., Messing R.O., Hodge C.W. Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCepsilon-deficient mice. European Journal of Neuroscience 2000, 12(11):4131-4140.
150. Olive M.F., Messing R.O. Protein kinase C isozymes and addiction. Molecular Neurobiology 2004, 29(2):139-154.
151. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Archives of General Psychiatry 1992, 49(11):881-887.
152. O'Malley S.S., Krishnan-Sarin S., Farren C., Sinha R., Kreek M.J. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl) 2002, 160(1):19-29.
153. Otis T.S., De Koninck Y., Mody I. Lasting potentiation of inhibition is associated with an increased number of gamma-aminobutyric acid type A receptors activated during miniature inhibitory postsynaptic currents. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(16):7698-7702.
154. Ouagazzal A.M., Moreau J.L., Pauly-Evers M., Jenck F. Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/orphanin FQ peptide precursor gene. Behavioural Brain Research 2003, 144(1-2):111-117.
155. Pandey S.C., Zhang H., Roy A., Xu T. Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. Journal of Clinical Investigation 2005, 115(10):2762-2773.
156. Pandey S.C., Zhang H., Ugale R., Prakash A., Xu T., Misra K. Effector immediate-early gene arc in the amygdala plays a critical role in alcoholism. Journal of Neuroscience 2008, 28(10):2589-2600.
157. Papadopoulou N., Chen J., Randeva H.S., Levine M.A., Hillhouse E.W., Grammatopoulos D.K. Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1 alpha receptor-extracellularly regulated kinase signal transduction pathway: The critical role of Ser(301) for signaling switch and selectivity. Molecular Endocrinology 2004, 18(3):624-639.
158. Pape H.C., Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiological Reviews 2010, 90(2):419-463.
159. Pare D., Quirk G.J., Ledoux J.E. New vistas on amygdala networks in conditioned fear. Journal of Neurophysiology 2004, 92(1):1-9.
160. Pare D., Smith Y. Distribution of GABA immunoreactivity in the amygdaloid complex of the cat. Neuroscience 1993, 57(4):1061-1076.
161. Pignataro L., Miller A.N., Ma L., Midha S., Protiva P., Herrera D.G., et al. Alcohol regulates gene expression in neurons via activation of heat shock factor 1. Journal of Neuroscience 2007, 27(47):12957-12966.
162. Pitkanen A., Jolkkonen E., Kemppainen S. Anatomic heterogeneity of the rat amygdaloid complex. Folia Morphol (Warsz) 2000, 59(1):1-23.
163. Pitkanen A., Pikkarainen M., Nurminen N., Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Annals of the New York Academy of Sciences 2000, 911:369-391.
164. Pitkanen A., Stefanacci L., Farb C.R., Go G.G., LeDoux J.E., Amaral D.G. Intrinsic connections of the rat amygdaloid complex: Projections originating in the lateral nucleus. Journal of Comparative Neurology 1995, 356(2):288-310.
165. Primeaux S.D., Wilson S.P., Bray G.A., York D.A., Wilson M.A. Overexpression of neuropeptide Y in the central nucleus of the amygdala decreases ethanol self-administration in "anxious" rats. Alcoholism, Clinical and Experimental Research 2006, 30(5):791-801.
166. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., et al. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. Journal of Neuroscience 2004, 24(14):3471-3479.
167. Rassnick S., Heinrichs S.C., Britton K.T., Koob G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Research 1993, 605(1):25-32.
168. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 270(5237):792-794.
169. Richardson H.N., Zhao Y., Fekete E.M., Funk C.K., Wirsching P., Janda K.D., et al. MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacology, Biochemistry and Behavior 2008, 88(4):497-510.
170. Roberto M., Bajo M., Crawford E., Madamba S.G., Siggins G.R. Chronic ethanol exposure and protracted abstinence alter NMDA receptors in central amygdala. Neuropsychopharmacology 2006, 31(5):988-996.
171. Roberto M., Cruz M., Bajo M., Siggins G.R., Parsons L.H., Schweitzer P. The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala. Neuropsychopharmacology 2010, 35(9):1962-1972.
172. Roberto M., Cruz M.T., Gilpin N.W., Sabino V., Schweitzer P., Bajo M., et al. Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biological Psychiatry 2010, 67(9):831-839.
173. Roberto M., Madamba S.G., Moore S.D., Tallent M.K., Siggins G.R. Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(4):2053-2058.
174. Roberto M., Madamba S.G., Stouffer D.G., Parsons L.H., Siggins G.R. Increased GABA release in the central amygdala of ethanol-dependent rats. Journal of Neuroscience 2004, 24(45):10159-10166.
175. Roberto M., Schweitzer P., Madamba S.G., Stouffer D.G., Parsons L.H., Siggins G.R. Acute and chronic ethanol alter glutamatergic transmission in rat central amygdala: An in vitro and in vivo analysis. Journal of Neuroscience 2004, 24(7):1594-1603.
176. Roberto M., Siggins G.R. Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(25):9715-9720.
177. Roberts A.J., Cole M., Koob G.F. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcoholism, Clinical and Experimental Research 1996, 20(7):1289-1298.
178. Roberts A.J., Gold L.H., Polis I., McDonald J.S., Filliol D., Kieffer B.L., et al. Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcoholism, Clinical and Experimental Research 2001, 25(9):1249-1256.
179. Roberts A.J., Heyser C.J., Cole M., Griffin P., Koob G.F. Excessive ethanol drinking following a history of dependence: Animal model of allostasis. Neuropsychopharmacology 2000, 22(6):581-594.
180. Roberts A.J., McDonald J.S., Heyser C.J., Kieffer B.L., Matthes H.W., Koob G.F., et al. μ-Opioid receptor knockout mice do not self-administer alcohol. Journal of Pharmacology and Experimental Therapeutics 2000, 293(3):1002-1008.
181. Rogers J., Wiener S.G., Bloom F.E. Long-term ethanol administration methods for rats: Advantages of inhalation over intubation or liquid diets. Behavioral and Neural Biology 1979, 27(4):466-486.
182. Roy A., Pandey S.C. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcoholism, Clinical and Experimental Research 2002, 26(6):796-803.
183. Sabino V., Cottone P., Koob G.F., Steardo L., Lee M.J., Rice K.C., et al. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 2006, 189(2):175-186.
184. Sajdyk T.J., Vandergriff M.G., Gehlert D.R. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. European Journal of Pharmacology 1999, 368(2-3):143-147.
185. Sakanaka M., Shibasaki T., Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Research 1986, 382(2):213-238.
186. Salin P.A., Scanziani M., Malenka R.C., Nicoll R.A. Distinct short-term plasticity at two excitatory synapses in the hippocampus. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(23):13304-13309.
187. Savander V., Go C.G., LeDoux J.E., Pitkanen A. Intrinsic connections of the rat amygdaloid complex: Projections originating in the basal nucleus. Journal of Comparative Neurology 1995, 361(2):345-368.
188. Schroeder J.P., Olive F., Koenig H., Hodge C.W. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration. Alcoholism, Clinical and Experimental Research 2003, 27(12):1884-1891.
189. Seino S., Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiological Reviews 2005, 85(4):1303-1342.
190. Semyanov A., Walker M.C., Kullmann D.M., Silver R.A. Tonically active GABA A receptors: Modulating gain and maintaining the tone. Trends in Neurosciences 2004, 27(5):262-269.
191. Siggins G.R., Roberto M., Nie Z. The tipsy terminal: Presynaptic effects of ethanol. Pharmacology and Therapeutics 2005, 107(1):80-98.
192. Sommer W.H., Rimondini R., Hansson A.C., Hipskind P.A., Gehlert D.R., Barr C.S., et al. Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biological Psychiatry 2008, 63(2):139-145.
193. Sparrow A.M., Lowery-Gionta E.G., Pleil K.E., Li C., Sprow G.M., Cox B.R., et al. Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors. Neuropsychopharmacology 2012, 37(6):1409-1421.
194. Sparta D.R., Sparrow A.M., Lowery E.G., Fee J.R., Knapp D.J., Thiele T.E. Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcoholism, Clinical and Experimental Research 2008, 32(2):259-265.
195. Spencer S.J., Xu L., Clarke M.A., Lemus M., Reichenbach A., Geenen B., et al. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biological Psychiatry 2012, 72(6):457-465.
196. Tasan R.O., Nguyen N.K., Weger S., Sartori S.B., Singewald N., Heilbronn R., et al. The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. Journal of Neuroscience 2010, 30(18):6282-6290.
197. Thiele T.E., Koh M.T., Pedrazzini T. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. Journal of Neuroscience 2002, 22(3):RC208.
198. Thiele T.E., Marsh D.J., Ste Marie L., Bernstein I.L., Palmiter R.D. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 1998, 396(6709):366-369.
199. Thorsell A. Neuropeptide Y (NPY) in alcohol intake and dependence. Peptides 2007, 28(2):480-483.
200. Thorsell A. Central neuropeptide Y in anxiety- and stress-related behavior and in ethanol intake. Annals of the New York Academy of Sciences 2008, 1148:136-140.
201. Trudeau L.E., Emery D.G., Haydon P.G. Direct modulation of the secretory machinery underlies PKA-dependent synaptic facilitation in hippocampal neurons. Neuron 1996, 17(4):789-797.
202. Tye K.M., Prakash R., Kim S.Y., Fenno L.E., Grosenick L., Zarabi H., et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011, 471(7338):358-362.
203. Valdez G.R., Platt D.M., Rowlett J.K., Ruedi-Bettschen D., Spealman R.D. Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: A role for opioid and stress-related mechanisms. Journal of Pharmacology and Experimental Therapeutics 2007, 323(2):525-533.
204. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: Regulation by corticotropin-releasing factor. Alcoholism, Clinical and Experimental Research 2002, 26(10):1494-1501.
205. Valdez G.R., Zorrilla E.P., Roberts A.J., Koob G.F. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol 2003, 29(2):55-60.
206. Veening J.G., Swanson L.W., Sawchenko P.E. The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: A combined retrograde transport-immunohistochemical study. Brain Research 1984, 303(2):337-357.
207. Walker B.M., Valdez G.R., McLaughlin J.P., Bakalkin G. Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence. Alcohol 2012, 46(4):359-370.
208. Wallner M., Hanchar H.J., Olsen R.W. Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(25):15218-15223.
209. Wan F.J., Berton F., Madamba S.G., Francesconi W., Siggins G.R. Low ethanol concentrations enhance GABAergic inhibitory postsynaptic potentials in hippocampal pyramidal neurons only after block of GABAB receptors. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(10):5049-5054.
210. Wang J.H., Kelly P.T. Attenuation of paired-pulse facilitation associated with synaptic potentiation mediated by postsynaptic mechanisms. Journal of Neurophysiology 1997, 78(5):2707-2716.
211. Wang L., Liu J., Harvey-White J., Zimmer A., Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(3):1393-1398.
212. Waselus M., Nazzaro C., Valentino R.J., Van Bockstaele E.J. Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. Biological Psychiatry 2009, 66(1):76-83.
213. Wee S., Koob G.F. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) 2010, 210(2):121-135.
214. Wei W., Faria L.C., Mody I. Low ethanol concentrations selectively augment the tonic inhibition mediated by delta subunit-containing GABAA receptors in hippocampal neurons. Journal of Neuroscience 2004, 24(38):8379-8382.
215. World Health Organization (2007) International Classification of Diseases. 10th revision. Retrieved from . http://apps.who.int/classifications/apps/icd/icd10online/.
216. Wurst F.M., Rasmussen D.D., Hillemacher T., Kraus T., Ramskogler K., Lesch O., et al. Alcoholism, craving, and hormones: The role of leptin, ghrelin, prolactin, and the pro-opiomelanocortin system in modulating ethanol intake. Alcoholism, Clinical and Experimental Research 2007, 31(12):1963-1967.
217. Xuei X., Flury-Wetherill L., Almasy L., Bierut L., Tischfield J., Schuckit M., et al. Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence. Addiction Biology 2008, 13(1):80-87.
218. Zhu W., Pan Z.Z. Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons. Neuroscience 2004, 127(4):871-879.
219. Zhu W., Pan Z.Z. μ-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 2005, 133(1):97-103.
220. Zorrilla E.P., Zhao Y., Koob G.F. Anti-CRF. Encyclopedia of Stress 2007, Vol 1 A-E:206-214. Elsevier, Amsterdam.
221. Zorrilla E.P., Valdez G.R., Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 2001, 158(4):374-381.
222. Zucker R.S. Short-term synaptic plasticity. Annual Review of Neuroscience 1989, 12:13-31.